ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 041,70
0,15%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. IceCure Medical Ltd (ICCM)

  7. IceCure Medical Ltd (ICCM) Actualités

ICCM IceCure Medical Ltd

1,05
0,03 (2,94%)
18 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
IceCure Medical Ltd ICCM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,03 2,94% 1,05 01:58:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,01 1,01 1,06 1,04 1,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/5/202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202414:30PRNUSIndependent Study Results in Japan Demonstrate Zero (0%)..
15/4/202414:35PRNUSIceCure Medical Reports Final ICE3 Breast Cancer..
03/4/202414:30PRNUSIceCure Medical Reports Full Year 2023 Financial Results:..
03/4/202413:11IHMARKETNEWSU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude..
02/4/202414:30PRNUSIceCure Submits FDA Regulatory Filing for New XSense™..
27/3/202413:30PRNUSIceCure Medical to Report 2023 Full Year Financial &..
19/3/202413:30PRNUSIceCure Medical Reports Positive Topline Results From ICE3..
12/3/202413:30PRNUSIceCure Receives Notice of Patent Allowance in Japan for a..
07/3/202414:30PRNUSIceCure Medical to Present at 34th Annual Oppenheimer..
04/3/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202414:30PRNUSIceCure's ProSense® a Promising Alternative Treatment for..
27/2/202414:00PRNUSFourth BRIIT Conference in India Features IceCure's..
26/2/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202414:00PRNUSStudy Using IceCure's ProSense® Treatment Results in 100%..
15/2/202414:00PRNUSIceCure's ProSense® to be Featured at Two Upcoming Medical..
30/1/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202414:00PRNUSU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo..
29/1/202414:00PRNUSIceCure Medical's Breast Cryoablation Gains Prominence in..
16/1/202414:00PRNUSIceCure Medical's ProSense® Featured at Indian Society of..
12/1/202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/1/202422:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202422:05GLOBEIceCure Medical Regains Compliance with Nasdaq Minimum..
10/1/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
03/1/202414:00PRNUSNew Study Reports IceCure's ProSense® Boosts Immune Response..
13/12/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202314:00PRNUSStudy Using IceCure's ProSense® Finds: "Cryoablation Allows..
29/11/202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202314:00PRNUSIceCure's ProSense® Deepens Regulatory Approval in India
28/11/202314:00PRNUSIceCure System Successfully Treated Kidney Cancer Tumor with..
15/11/202314:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202314:00PRNUSIceCure Medical Reports Financial Results as of and for the..
15/11/202313:30PRNUSIceCure Medical Files Appeal with U.S. FDA Requesting a..
08/11/202314:00PRNUSIceCure Medical to Report Third Quarter 2023 Financial &..
06/11/202314:00PRNUSSubstantial Evidence-Based Data Currently Being Generated by..
03/11/202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202321:00PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
30/10/202313:00PRNUSIceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence..
25/10/202314:00PRNUSIndependent Scientific Paper by Doctors Using IceCure's..
05/10/202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202314:00PRNUSWomen Deemed Inoperable for Breast Cancer Benefitted from..
02/10/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202314:00PRNUSIndependent Study Validates IceCure's ProSense Cryoablation..
22/9/202314:00PRNUSRenowned Spanish Radiologist Lucía Graña-López to Present..
20/9/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202313:00PRNUSIceCure Medical Receives FDA Response to De Novo..
08/9/202314:00PRNUSIceCure Medical to Join Hands-On Cryoablation Session with..
05/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
ICCM
IceCure Medical
LSE
XWTS
Xworld Comm Ser
USOTC
WSCO
Wall Street Media (QB)
LSE
96HB
Man Air Gp 39
LSE
IGRE
Ing Global Real Estate Secs
LSE
XCMC
Xbbg Comm Sw 1c
NYSE
AEM
Agnico Eagle Mines
LSE
JHTE
LSE
SBDS
Silver Bullet Data Servi...
TG
WNRG
WisdomTree Energy Enhanc...
USOTC
ESLOY
Essilor Luxottica (PK)
TG
AHC
Hess
NYSE
BH
Biglari
LSE
AGTA
Agriterra Ld
BOV
HBOR3Q
HELBOR ON
EU
ALMDP
Medesis Pharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés